1 min
Retatrutide Safety Profile Phase 3 Discontinuations Bmi Correlation
Discover the retatrutide safety profile from Phase 3 trials, including 18.2% discontinuation rates at 12mg dose, strong BMI correlation with lower rates in higher BMI patients, side effects like dysesthesia, and long-term data.
title: "Retatrutide Safety Profile: Phase 3 Discontinuations and BMI Correlation" description: "Discover the retatrutide safety profile from Phase 3 trials, including 18.2% discontinuation rates at 12mg dose, strong BMI correlation with lower rates in higher BMI patients, side effects like dysesthesia, and long-term data." date: "2025-04-21" tags: ["retatrutide", "phase
Model Your Retatrutide Kinetics & Titration
Calculate half-life decay curves, resting heart rate impact, and protein targets with our evidence-based metabolic calculators.
Retatrutide Titration & Kinetics Companion
Model your serum accumulation, half-life decay, and titration protocol with our interactive planner—the prototype for our upcoming Metabolic OS companion app.
100% independent • Zero pharma sponsorship • Ad-free